Reuters : California reports five possible human bird flu cases

California reports five possible human bird flu cases

Oct 14 (Reuters) - California is investigating five possible human cases of bird flu among dairy farm workers, in addition to the six cases previously confirmed in the state, the state health department said on Monday.

Bird flu has spread to 100 dairies in California and 300 nationwide, according to the U.S. Department of Agriculture. There have been 19 confirmed human cases this year among farm workers exposed to sick poultry or dairy, including the six confirmed cases in California this month.

The risk to the general public from bird flu remains low and pasteurized dairy products are safe to consume, federal officials have said.

Specimens from the five possible cases are being sent to the Centers for Disease Control and Prevention for confirmation and are expected to arrive early this week, said the California Department of Public Health.

The possible and confirmed cases originated on nine different dairy farms and the individuals had mild symptoms and were not hospitalized, the state said.

WSJ : Citi Sees Possibility of $120 Oil if Supplies Are Disrupted

Citi Sees Possibility of $120 Oil if Supplies Are Disrupted
The bull-case scenario is based on the risk of an escalation of the conflict between Israel and Iran

Crude oil prices could go into triple digits if supplies are disrupted by conflict in the Middle East, despite weak market fundamentals, analysts at Citi Research said Monday in a report.

Citi said its base case is still for international benchmark Brent to average $74 a barrel in the fourth quarter and $65 a barrel in the first quarter of 2025, “owing to weak underlying oil market fundamentals.”

But analysts increased their bull-case estimate to $120 from $80 a barrel for the fourth quarter and first quarter of next year, while assigning such an outcome a probability of 20%, up from 10% previously.

“Our new bull case scenario is based on supply fears and disruptions similar in magnitude and duration to that which occurred during 2022,” Citi said, referring to the Russian invasion of Ukraine which caused a spike in oil prices. Actual supply losses at that time peaked at less than 1 million barrels a day, well below expectations of losses between 2 million and 3 million barrels a day, Citi said.

Although disruptions from an escalation in the current conflict between Israel and Iran could be higher than at the outbreak of the Russia-Ukraine conflict, “higher levels of spare capacity and stock levels, and a weakening demand environment, may mean a similar price response,” Citi added.

Citi’s bear-case scenario, which includes OPEC+ starting to raise production in December and a decline in supply risks, sees Brent at $60 a barrel in the fourth quarter and $55 in the first quarter of 2025.

Current risks include an Israeli strike on Iranian oil infrastructure or effects on oil flows through the Strait of Hormuz, Citi said, adding that it sees the latter event as highly unlikely. “Supply losses might also come from any response by Iran that targets regional energy assets,” Citi added.

The heightened tension with the market awaiting Israel’s response to Iran’s Oct. 1 missile attack has sent crude prices higher, although the increased risk premium has been offset by continuing concerns about weakening global demand, particularly from China. Oil prices were lower Monday after the Chinese government at the weekend offered few details of its economic stimulus plan, and OPEC cut its oil demand growth estimates for this year and 2025.

FT : Google orders small modular nuclear reactors for its data centres

Google orders small modular nuclear reactors for its data centres
Tech group signs deal with Kairos Power to build up to seven small facilities to meet its energy needs

Google has ordered six to seven small modular nuclear reactors (SMRs) from Kairos Power, becoming the first tech company to commission new nuclear power plants to provide low-carbon electricity for its energy-hungry data centres. 

Google and Kairos said on Monday that the tech company had placed an order for SMRs with a total capacity of 500MW, helping Kairos, a seven-year-old start-up, to bring its first commercial reactor online by 2030 and additional reactors by 2035. 

The agreement was “a landmark for us at Google in our 15-year clean energy journey”, said Michael Terrell, the company’s senior director of energy and climate.

“We feel nuclear can play an important role in helping us to meet our demand, and helping us to meet our demand cleanly and round the clock,” he said.

Asked if the reactors would feed into the grid or be directly connected to data centres, Terrell said Google was considering all options. 

The two companies declined to comment on the agreement’s value, or on whether Google would fund the construction of the SMRs upfront or simply pay for power once they were built. 

Last month, Microsoft announced that it would commit to buying 20 years’ supply of electricity from the mothballed US nuclear power plant Three Mile Island if Constellation Energy restarted the site. Tech companies are increasingly interested in nuclear as a medium-term solution to providing low-carbon electricity to meet their data centres’ energy demands. 

Google’s deal with Kairos is the first in which a tech company is helping to commission the building of a nuclear power plant. The US has brought only three reactors online in the past 20 years. 

Terrell said SMRs offered “a simplified, inherently safe design, faster construction, and flexibility on deployment location” compared with large- scale nuclear plants. “Obviously, this is a bit of a longer-term bet, but it is an incredibly promising bet. If we can get it to scale globally, this will deliver enormous benefits to power grids around the world.”

While Google was leaning “heavily” on renewable energy to power its data centres, Terrell added, its modelling had made clear “that to really get grids to be carbon-free it will take more than just wind, solar and lithium ion storage; you are going to need this next set of advanced technologies”. 

Kairos, based in Alameda, California, has developed a reactor cooled by molten fluoride salt, rather than water. In December, it received a construction permit from the US Nuclear Regulatory Commission to build a 50MW demonstration reactor in Tennessee called Hermes. 

This was the first approval for a new type of reactor in the US for half a century. The US Department of Energy is investing about $300mn in Kairos’s Hermes project through its Advanced Reactor Demonstration programme. 

The US has thrown its weight behind companies seeking to build smaller nuclear reactors that can be built in factories and assembled on site, in order to cut costs and speed up the construction of plants. 

Kairos’s molten salt reactor uses ceramic-coated TRISO fuel and operates at close to atmospheric pressure, transferring heat from the salt to generate steam and run a turbine. 

The company began construction on its Hermes project in July and is aiming for it to be operational by 2027. In September, it said it would build a salt-production facility and two fuel labs in Albuquerque, New Mexico.

Mike Laufer, Kairos’s chief executive, said the commercial-scale SMRs that the company planned to build for Google would have a capacity of 75MW and that the company was focusing on the US market.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • BA -2.4% (issues downside Q3 revenue guidance; making important strategic decisions to restore the company;to reduce the size of its total workforce by roughly 10%; expects 777x first delivery in 2026)
Other news:
  • BTU -1.5% (provides update on Centurion metallurgical coal mine development)
  • AMGN -1.2% (positive Barron's article)
  • EG -1% (positive Barron's article)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • NRIX +2.8%
Other news:
  • IVA +70.4% (announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study)
  • LBPH +50.6% (to be acquired by Lundbeck (HLUYY) for $60.00 per share in cash)
  • JSPR +25.8% (reports preliminary data from the Company's ongoing SPOTLIGHT Phase 1b/2a study of subcutaneous briquilimab)
  • RILY +17.8% (establishes partnership with Oaktree in the Great American Group Businesses)
  • BLCO +8.7% (Blackstone (BX) and TPG considering joint bid for BLCO, according to FT; receives FDA approval for full range of enVista Envy)
  • SUUN +8.4% (plans 7-Megawatt Solar Project in Development by SolarBank in Pennsylvania)
  • VNDA +8.3% (Cycle Pharmaceuticals mulling acquisition of VNDA, according to Bloomberg)
  • VRA +6.9% (Board of Directors unanimously approves the adoption of a limited duration shareholder rights to guard against "abusive tactics so that no person, entity or group can gain a control or control-like postion")
  • RDHL +5.6% (Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment)
  • SIRI +3.9% (Berkshire Hathaway's (BRK.A / BRK.B) Warren Buffett bought 3,564,059 shares at $22.96 - $25.14 worth approx. $86.7 mln)
  • RDW +3.2% (prepares for a major European satellite delivery in the fourth quarter as international customer demand increases)
  • BNTC +2.7% (Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society)
  • ODV +2.4% (closes final tranche of non-brokered private placement for total aggregate proceeds of $34.5 mln)
  • GATO +1.6% (disclosed material elements of the Company's June 21, 2024 response to a comment letter issued by the SEC, dated June 6, 2024, relating to the SEC's review)
  • NTRA +1.5% (positive Barron's article)
  • TMHC +1% (positive Barron's article)

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Affirm (AFRM) upgraded to Neutral from Underperform at Wedbush; tgt $45
    • AptarGroup (ATR) upgraded to Buy from Hold at Jefferies; tgt raised to $215
    • Easterly Government Properties (DEA) upgraded to Buy from Hold at Jefferies; tgt raised to $15
    • Elastic (ESTC) upgraded to Outperform from Mkt Perform at William Blair
    • Equinor (EQNR) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt $25.80
    • Flutter Entertainment (FLUT) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $295
    • Ibotta (IBTA) upgraded to Buy from Neutral at Goldman; tgt $87
    • SentinelOne (S) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $32
    • TC Energy (TRP) upgraded to Overweight from Neutral at JP Morgan
    • Upstart (UPST) upgraded to Neutral from Underperform at Wedbush; tgt raised to $45
  • Downgrades:
    • Amer Sports (AS) downgraded to Equal Weight from Overweight at Wells Fargo; tgt raised to $19
    • Amgen (AMGN) downgraded to Hold from Buy at Truist; tgt raised to $333
    • AppLovin (APP) downgraded to Neutral from Buy at Goldman; tgt raised to $150
    • ArcBest (ARCB) downgraded to Hold from Buy at TD Cowen; tgt lowered to $114
    • AutoZone (AZO) downgraded to Sell from Buy at Goldman; tgt lowered to $2917
    • BASF AG (BASFY) downgraded to Neutral from Buy at UBS
    • Bridge Investment Group (BRDG) downgraded to Hold from Buy at TD Cowen; tgt raised to $10.50
    • Canada Goose (GOOS) downgraded to Underweight from Equal Weight at Wells Fargo
    • Caterpillar (CAT) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $332
    • Duolingo (DUOL) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
    • Expeditors Intl (EXPD) downgraded to Sell from Hold at TD Cowen; tgt lowered to $106
    • First Busey Corp (BUSE) downgraded to Equal-Weight from Overweight at Stephens
    • KeyCorp (KEY) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $17
    • Kura Oncology (KURA) downgraded to Hold from Buy at Stifel; tgt lowered to $19
    • Marten Transport (MRTN) downgraded to Mkt Perform from Outperform at Raymond James
    • Triumph Group (TGI) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $12
    • Turnstone Biologics (TSBX) downgraded to Neutral from Buy at BofA Securities
    • V.F. Corp (VFC) downgraded to Underweight from Equal Weight at Wells Fargo; tgt lowered to $15
    • Yelp (YELP) downgraded to Neutral from Buy at Goldman; tgt lowered to $38
  • Others:
    • Adecoagro S.A. (AGRO) initiated with a Neutral at UBS; tgt $12
    • Alpine Income Property Trust (PINE) initiated with a Neutral at UBS; tgt $19
    • Amentum Holdings (AMTM) initiated with a Buy at Truist; tgt $31
    • Apple (AAPL) added to Evercore ISI's Tactical Outperform list
    • Astrana Health (ASTH) initiated with a Buy at TD Cowen; tgt $66
    • Diamondback Energy (FANG) resumed with a Neutral at Citigroup; tgt $195
    • Element Solutions (ESI) initiated with a Buy at Seaport Research Partners; tgt $33
    • FirstEnergy (FE) initiated with a Hold at Jefferies; tgt $46
    • ICU Medical (ICUI) initiated with a Hold at Jefferies; tgt $183
    • Jamf Holding (JAMF) initiated with an Equal-Weight at Morgan Stanley; tgt $20
    • MindMed (MNMD) resumed with an Outperform at Leerink Partners; tgt $20
    • NCR Voyix Corporation (VYX) resumed with a Neutral at Goldman; tgt $14
    • NETSTREIT (NTST) initiated with a Buy at UBS; tgt $19
    • PG&E (PCG) initiated with a Buy at Jefferies; tgt $24
    • Regal Rexnord (RRX) initiated with a Buy at Citigroup; tgt $200
    • Shoals Technologies (SHLS) initiated with an Equal Weight at Wells Fargo; tgt $46
    • Stoke Therapeutics (STOK) resumed with an Outperform at Leerink Partners; tgt $18
    • Surgery Partners (SGRY) initiated with a Buy at UBS; tgt $38
    • Tenax Therapeutics (TENX) initiated with a Buy at Guggenheim; tgt $16
    • Timken (TKR) initiated with a Neutral at Citigroup; tgt $90
    • Vistra Corp. (VST) initiated with an Outperform at Exane BNP Paribas; tgt $231